Fermer le menu


Member of Lyonbiopole


PDC*line Pharma is a clinical-stage biotech that develops potent and scalable off-the-shelf therapeutic cancer vaccines based on the only cell line of Dendritic Cells for therapeutic use (PDC*line). Spin-off of the EFS (French blood service), PDC*line Pharma was founded in 2014 and won national awards including the first start-up prize of MATWINl in 2017, and the first life sciences prize of Tremplin Entreprises 2015.


Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Cell Therapy - Stem cells - Cell Biology - Biobanking, Vaccine

Created on april 1st, 2014 - 5 employees



29 avenue des Maquis du Grésivaudan La Tronche 38701



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.